Retrovirus-mediated transfer of the herpes simplex type I thymidine kinase gene in alloreactive T lymphocytes

Human Gene Therapy

Volumn 9, Issue 1, 1998, Pages 73-80

  Contassot, Emmanuel ^a   Ferrand, Christophe ^a   Certoux, Jean Marie ^a   Reynolds, Craig W ^b   Jacob, William ^c   Chiang, Yawen ^c   Cahn, Jean Yves ^d   Hervé, Patrick ^a   Tiberghien, Pierre ^a  

^a Etablissement de Transfus Sanguine   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC G 418; GANCICLOVIR; THYMIDINE KINASE;

ALLOIMMUNITY; ARTICLE; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; RETROVIRUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS GENE;

EID: 0031975970     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.1-73     Document Type: Article

References (10)

1. BURAKOFF, S.J., DEEG, H.J., FERRARA, J., and ATKINSON, K. (eds). (1990). Graft-versus-Host Disease: Immunology, Physiopathology and Treatment, Hematology, Vol 12. (Marcel Dekker, New York).
2. CAMOLI, P., MONTAGNA, D., MORETTA, A., ZECCA, M., LOCATELLI, F., and MACCARO, R. (1995). Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro. J. Immunol. 155, 5506-5511.
3. CAVAZZANA-CALVO, M., FROMONT, C., LE DEIST, F., LUSARDI, M., COULOMBEL, L., DEROCQ, J.M., GEROTA, I., GRISCELLI, C., and FISCHER, A. (1990). Specific elimination of alloreactive T cells by an anti-interleukin-2 receptor B chain-specific immunotoxin. Transplantation 50, 1-7.
4. CAVAZZANA-CALVO, M., STEPHAN, J.L., SARNACKI, S., CHEVRET, S., FROMONT, C., DE COENE, C., LE DEIST, F., GUY-GRAND, D., and FISCHER, A. (1994). Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination. Blood 83, 288-295.
5. CEREB, N., and SOO YOUNG, Y. (1996). Induction of microvariant-specific CTL lines reactive to a single amino acid mismatch in bulk cultures using a transfectant expressing a single HLA class I molecule. J. Immunol. 156, 18-26.
6. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLD-FIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
7. FLETCHER, C., SAWCHUK, R., CHINNOCK, B., MIRANDA, P., and BALFOUR, H.H. (1986). Human pharmacokinetics of the antiviral drug DHPG. Clin. Pharmacol. Then 40, 281.
8. HOROWITZ, M.M., GALE, R.P., SONDEL, P.M., GOLDMAN, J.M., KERSEY, J., KOLB, H.J., RIMM, A.A., RINGDEN, O., ROZMAN, C., SPECK, B., TRUITT, R.L., ZWAAN, F.E., and BORTIN, M.M. (1990). Graft-versus-Leukemia reactions after bone marrow transplantation. Blood 75, 555-562.
9. KADAN, M.J., STURM, S., ANDERSON, W.F., and EGLITIS, M.A. (1992). Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J. Virol. 66, 2281-2287.
10. KOTANI, H., NEWTON, P.B., ZHANG, S., CHIANG, A.L., OTTO, E., WEAVER, L., BLAESE, R.M., FRENCH ANDERSON, W., and MCGARRTTY, G. (1994). Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Then 5, 19-28.